Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience

BACKGROUND: Glioblastoma is usually diagnosed around the age of 60–70 years. Patients older than 65 years are frequently described as “elderly”. Several trials with monotherapy have established treatment regimens that offer therapies with reduced side effects but reduced efficacy. We analysed the ou...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Radiat Oncol
Main Authors: Straube, Christoph, Scherb, Hagen, Gempt, Jens, Bette, Stefanie, Zimmer, Claus, Schmidt-Graf, Friederike, Schlegel, Jürgen, Meyer, Bernhard, Combs, Stephanie E.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408447/
https://ncbi.nlm.nih.gov/pubmed/28454549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0809-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki